Public health by organizational fix?


Journal

Health economics, policy, and law
ISSN: 1744-134X
Titre abrégé: Health Econ Policy Law
Pays: England
ID NLM: 101247224

Informations de publication

Date de publication:
Jul 2023
Historique:
medline: 12 6 2023
pubmed: 14 4 2023
entrez: 13 4 2023
Statut: ppublish

Résumé

In August 2020 the UK government announced without warning the abolition of Public Health England (PHE), the principal UK agency for the promotion and protection of public health. We undertook a research programme seeking to understand the factors surrounding this decision. While the underlying issues are complex two competing interpretations have emerged: an 'official' explanation, which highlights the failure of PHE to scale up its testing capacity in the early weeks of the COVID-19 pandemic as the fundamental reason for closing it down and a 'sceptical' interpretation, which ascribes the decision to blame-avoidance behaviour on the part of leading government figures. This paper reviews crucial claims in these two competing explanations exploring the arguments for and against each proposition. It concludes that neither is adequate and that the inability adequately to address the problem of testing (which triggered the decision to close PHE) lies deeper in the absence of the norms of responsible government in UK politics and the state. However our findings do provide some guidance to the two new organizations established to replace PHE to maximize their impact on public health. We hope that this information will contribute to the independent national COVID inquiry.

Identifiants

pubmed: 37051924
doi: 10.1017/S1744133123000051
pii: S1744133123000051
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

274-288

Auteurs

Albert Weale (A)

School of Public Policy, University College London, London, UK.

David J Hunter (DJ)

Newcastle University, Newcastle upon Tyne, UK.

Peter Littlejohns (P)

Kings College London, London, UK.

Toslima Khatun (T)

Kings College London, London, UK.

Jacqueline Johnson (J)

University College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH